Guardion Health Sciences, Inc.: key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023)

$12.2M

Net Income/Loss (FY2023)

$158.0K

Total Assets (FY2023)

$11.9M

Total Equity (FY2023)

$2.9M

Cash Flows from Operating Activities (FY2023)

-$4.4M

Source: Guardion Health Sciences, Inc. 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.